# E134: Brepocitinib in Dermatomyositis (VALOR)

Page: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e134-brepocitinib-in-dermatomyositis-valor
Text version: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e134-brepocitinib-in-dermatomyositis-valor.md
Podcast: [The Evidence Based Rheumatology Podcast](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175)
Published: 2026-04-17T20:06:48+00:00
Episode link: https://msputman.podbean.com/e/e134-brepocitinib-in-dermatomyositis-valor/
Audio file: https://mcdn.podbean.com/mf/web/yz9465wkvuzhurxw/e134.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e134-brepocitinib-in-dermatomyositis-valor
Duration seconds: 898

## Resource

Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be approved. Where it fits in our approach to IIM is an open question, but nice to have another option. Study: https://www.nejm.org/doi/10.1056/NEJMoa2503531 JC Companion: https://autoimmunedevreport.substack.com/

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e134-brepocitinib-in-dermatomyositis-valor/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e134-brepocitinib-in-dermatomyositis-valor.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.